NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Malek Chamoun185.03%3,700,000$7.88MInsider
Camille Sebaaly8.72%174,465$371.61kInsider
Steve N. Slilaty6.50%130,000$276.90kInsider
Connective Capital Management LLC0.57%11,345$24.16kInstitution
Morgan Stanley0.38%7,640$16.27kInstitution
Ubs Group Ag0.04%868$1.85kInstitution
Sbi Securities Co Ltd0.04%709$1.51kInstitution
National Bank Of Canada0.00%7$14.91Institution
Bank Of America Corp0.00%5$10.65Institution
Northwestern Mutual Wealth Management Co0.00%4$8.52Institution

1 of 2

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM0.51%99.49%
EVOK1.82%98.18%Net BuyingNet Buying
IMCC5.41%0.00%
QNTM9.57%0.00%
SNOA0.52%99.48%

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 1.03% institutional shareholders, 200.26% Sunshine Biopharma insiders, and 0.00% retail investors. Malek Chamoun is the largest individual Sunshine Biopharma shareholder, owning 3.70M shares representing 185.03% of the company. Malek Chamoun's Sunshine Biopharma shares are currently valued at $7.88M.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.